5Y Capital
Chinese early-stage fund (formerly Morningside Venture Capital) investing in technology and life sciences.
5Y Capital is solid if you're a China or SEA-focused startup that needs cross-border expertise, but they're not your typical Silicon Valley hand-holders. They move fast, have strong conviction when they invest, and their Sequoia alumni bring real operational chops. The downside? They can be pretty demanding on metrics and governance - expect monthly board decks and detailed KPI tracking from day one. Their network in Asia is genuinely valuable, but if you're purely US-focused, there are probably better fits. They're particularly strong on the enterprise side and have helped several portfolio companies expand internationally.
- —Best for: Cross-border startups needing Asia market entry
- —Watch out for: High operational expectations and detailed reporting
- —Known for: Strong fintech/enterprise networks in China and SEA
5Y Capital focuses on early-stage technology investments in China and Southeast Asia, with particular emphasis on enterprise software, fintech, and consumer internet. They position themselves as a bridge between Chinese capital and global markets, seeking companies that can scale across borders.
Series A to Series B investments, typically $5-20M checks, primarily in Chinese and Southeast Asian startups across enterprise SaaS, fintech, logistics tech, and consumer platforms. Heavy concentration in B2B software and financial services infrastructure.
Former VP at Qiming Venture Partners with 15+ years in venture capital. Known for enterprise software investments and strong networks in both China and Silicon Valley. Founders appreciate his operational experience but note he can be very direct in board meetings.
Ex-Sequoia Capital China partner who led investments in several unicorns including Airwallex. Highly respected for cross-border deal sourcing and has strong relationships with US institutional investors. Known as tough but fair in negotiations.
Have a specific question about 5Y Capital?
Ask Bernie →